Literature DB >> 26423636

Patient-reported Outcome Measures in Radiotherapy: Clinical Advances and Research Opportunities in Measurement for Survivorship.

S Faithfull1, A Lemanska2, T Chen3.   

Abstract

Patient-reported outcome measures (PROMs) are a useful way of recording patient perceptions of the impact of their cancer and the consequences of treatment. Understanding the impact of radiotherapy longer term requires tools that are sensitive to change but also meaningful for patients. PROMs are useful in defining symptom severity but also the burden of illness for cancer patients. Patient-reported outcomes are increasingly being seen as a way to improve practice by enhancing communication, improving symptom management as well as identifying patient care needs. This paper provides an overview of the use of PROMs in radiotherapy and considerations for tool choice, analysis and the logistics of routine data collection. Consistent assessment is essential to detect patient problems as a result of radiotherapy, but also to address emerging symptoms promptly.
Copyright © 2015 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Multidimensional measures; PROMs; survivorship

Mesh:

Year:  2015        PMID: 26423636     DOI: 10.1016/j.clon.2015.07.007

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  6 in total

1.  Patient-reported symptoms of radiation dermatitis during breast cancer radiotherapy: a pilot study.

Authors:  Jieun Lee; Won Park; Doo Ho Choi; Seung Jae Huh; Im-Ryung Kim; Danbee Kang; Juhee Cho
Journal:  Qual Life Res       Date:  2017-02-25       Impact factor: 4.147

2.  Patient-reported outcome measures in oncology: a qualitative study of the healthcare professional's perspective.

Authors:  Caitlin Graupner; S O Breukink; S Mul; D Claessens; A H M Slok; M L Kimman
Journal:  Support Care Cancer       Date:  2021-03-02       Impact factor: 3.603

3.  Symptom clusters for revising scale membership in the analysis of prostate cancer patient reported outcome measures: a secondary data analysis of the Medical Research Council RT01 trial (ISCRTN47772397).

Authors:  Agnieszka Lemanska; Tao Chen; David P Dearnaley; Rajesh Jena; Matthew R Sydes; Sara Faithfull
Journal:  Qual Life Res       Date:  2017-03-28       Impact factor: 4.147

4.  Women's Free-text Comments on their Quality of Life: An Exploratory Analysis from the UK Standardisation of Breast Radiotherapy (START) Trials for Early Breast Cancer.

Authors:  J Mills; J S Haviland; C Moynihan; J M Bliss; P Hopwood
Journal:  Clin Oncol (R Coll Radiol)       Date:  2018-04-10       Impact factor: 4.126

5.  Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial.

Authors:  Indrani S Bhattacharya; Joanne S Haviland; Penelope Hopwood; Charlotte E Coles; John R Yarnold; Judith M Bliss; Anna M Kirby
Journal:  Radiother Oncol       Date:  2019-02-28       Impact factor: 6.280

Review 6.  Cancer survivorship: an integral part of Europe's research agenda.

Authors:  Pernilla Lagergren; Anna Schandl; Neil K Aaronson; Hans-Olov Adami; Francesco de Lorenzo; Louis Denis; Sara Faithfull; Lifang Liu; Franḉoise Meunier; Cornelia Ulrich
Journal:  Mol Oncol       Date:  2019-01-08       Impact factor: 6.603

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.